Equities

Nidan Laboratories and Healthcare Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Nidan Laboratories and Healthcare Ltd

Actions
  • Price (INR)17.50
  • Today's Change0.50 / 2.94%
  • Shares traded2.00k
  • 1 Year change-18.79%
  • Beta0.6497
Data delayed at least 15 minutes, as of Feb 18 2026 06:27 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Nidan Laboratories and Healthcare Limited is an India-based company. The Company is engaged in providing diagnostic services including pathology, radiology, cardiology, and neurology. Its laboratory tests offer a range of over 6000 clinical laboratory tests and profiles, which are used to provide diagnostic services for prediction, early detection, diagnostic screening, confirmation and/or monitoring of the disease using technological advanced machines, prenatal screening, to screening for hormonal imbalance, nutritional deficiencies, and tracking lifestyle disorders. Its services include computed tomography (CT) scans, X-radiation (X-ray), pathology, cardio, magnetic resonance imaging (MRI), sonography, outpatient department (OPD) and others. Its lab tests include CT Lower Limb Arteriography And Venography, CT Whole Spine, CT Abdomen Angiography, CT Lumber Spine, CT Calcium Scoring, Dry Film D12, CT Extra Report and others.

  • Revenue in INR (TTM)271.16m
  • Net income in INR23.09m
  • Incorporated2000
  • Employees163.00
  • Location
    Nidan Laboratories and Healthcare LtdSwapnshilpaBehind Aarti Apartment, Vartak Road,PALGHAR 401303IndiaIND
  • Phone+91 2 502500004
  • Websitehttps://www.nidanhealthcare.co.in/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nidan Laboratories and Healthcare Ltd271.16m23.09m236.30m163.0010.230.33945.490.87151.661.6619.5250.080.32051.7120.281,663,546.002.731.943.162.3597.3493.358.525.891.159.120.1522--1.452.02161.1622.57154.54--
Data as of Feb 18 2026. Currency figures normalised to Nidan Laboratories and Healthcare Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.